For CFOs, ASCs represent both opportunity and risk.
The Ambulatory Surgery Center (ASC) market is no longer a fringe play. For health system CFOs, the trend presents a compelling growth frontier but one that requires disciplined capital decisions, operational vigilance, and strategic alignment.
A recent report shows that Private equity and health system investments in ASCs surpassed $19 billion in 2024, signaling that scale, efficiency, and partnership models are vital for competitiveness in outpatient care delivery. ASCs now generate more than $45 billion in annual revenue, with projections topping $57 billion by 2030.
CFOs that fail to proactively engage may leave their organizations that remain hospital-centric exposed to margin pressure, while those that lean into the ASC opportunity with strategic clarity stand to gain a differentiated competitive and financial position.
Here are some strategies CFOs can consider when crafting their ASC strategy.
For a deeper dive, check out the accompanying article.
Marie DeFreitas is the CFO editor for HealthLeaders.